Scribe Therapeutics Inc. (SCTX)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$21.32−$0.2938 (−1.36%) on the dayAs of the close; data may be delayed.
SCTX price, last 12 months
Key stats
- Previous close
- $21.61
- Open
- $23.20
- Day range
- $20.21 – $23.66
- 52-week range
- $17.31 – $39.60
- Volume
- 437.9K
- Avg volume (20 days)
- 378.7K
- Market cap
- $402.9M
Performance
1W−35.4%
1M−32.8%
3M—
6M—
YTD—
1Y—
Technicals and fundamentals
About Scribe Therapeutics Inc.
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $402.9M